Harvard Bioscience (HBIO) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 31.80% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -37.96% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 19.70% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 0.27% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 15.63% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 8.70% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -72.19% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 10.06% |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn | -95.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.79% |
| Dec 31, 2025 | -16.25% |
| Sep 30, 2025 | 28.76% |
| Jun 30, 2025 | -43.21% |
| Mar 31, 2025 | -93.72% |
| Dec 31, 2024 | -68.75% |
| Sep 30, 2024 | -204.55% |
| Jun 30, 2024 | -88.21% |
| Mar 31, 2024 | -91.44% |
| Dec 31, 2023 | -30.89% |
| Sep 30, 2023 | -3.58% |
| Jun 30, 2023 | 14.74% |
| Mar 31, 2023 | 28.82% |
| Dec 31, 2022 | -81.05% |
| Dec 31, 2021 | 49.36% |
| Jun 30, 2021 | -145.00% |
| Mar 31, 2021 | -33.41% |
| Dec 31, 2020 | -39.28% |
| Sep 30, 2020 | -90.29% |
| Jun 30, 2020 | -105.66% |
| Mar 31, 2020 | -140.91% |
| Dec 31, 2019 | 34.20% |
| Dec 31, 2018 | 70.43% |
| Jun 30, 2018 | -53.99% |
| Mar 31, 2018 | 48.50% |
| Dec 31, 2016 | -38.02% |
| Sep 30, 2016 | -20.55% |
| Jun 30, 2016 | -36.23% |
| Mar 31, 2016 | 8.67% |
| Dec 31, 2015 | -100.58% |
| Dec 31, 2013 | 52.42% |
| Sep 30, 2013 | -27.52% |
| Jun 30, 2013 | -29.06% |